Catalyst Wire Dossier Catalyst Wire Dossier

Lucanix

· NovaRx Corporation
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Lucanix, covering 2010-07-29 to 2015-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy [Phase 3]

See pricing